共 323 条
[1]
Matsuda T(2011)Cancer incidence and incidence rates in Japan in 2005: based on data from 12 population-based cancer registries in the monitoring of cancer incidence in Japan (MCIJ) project Jpn J Clin Oncol 41 139-147
[2]
Marugame T(2010)Cancer statistics, 2010 CA Cancer J Clin 60 277-300
[3]
Kamo K(2009)American society of clinical oncology clinical practice guideline update on chemotherapy for stage IV non-small cell lung cancer J Clin Oncol 27 6251-6266
[4]
Katanoda K(2002)Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer N Engl J Med 346 92-98
[5]
Ajiki W(2005)Erlotinib in previously treated non-small-cell lung cancer N Engl J Med 353 123-132
[6]
Sobue T(2005)Approval summary for erlotinib for treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of at least one prior chemotherapy regimen Clin Cancer Res 11 6414-6421
[7]
Jemal A(2010)Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR N Engl J Med 362 2380-2388
[8]
Siegel R(2009)Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma N Engl J Med 361 947-957
[9]
Xu J(2006)Prospective phase II study of gefitinib for chemotherapy-naive patients with advanced non-small-cell lung cancer with epidermal growth factor receptor gene mutations J Clin Oncol 24 3340-3346
[10]
Ward E(2007)Mutations of the epidermal growth factor receptor gene and related genes as determinants of epidermal growth factor receptor tyrosine kinase inhibitors sensitivity in lung cancer Cancer Sci 98 1817-1824